Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia

Current Psychiatry Reports
James M Wilkins, Brent P Forester

Abstract

Neuropsychiatric symptoms (NPS) of dementia including agitation, depression, and psychosis are common and debilitating facets of the disease process. Despite the significant impact of these symptoms on both individuals with dementia and their caregivers, safe and effective treatment options are lacking. From a pharmacological approach, antipsychotics have historically been the treatment of choice, but these medications are only modestly effective with significant adverse effects. Behavioral and psychosocial interventions have been shown to be effective but are difficult to implement in routine clinical practice. SSRI medications have been investigated as an alternative psychopharmacological approach based on evidence that the serotoninergic system is involved in the etiology of NPS in dementia. The evidence base for using SSRI medications in the treatment of NPS is growing, but the applicability of research findings to the utility of SSRIs in general in routine clinical practice is not entirely clear at this point. Further studies of a variety of SSRI medications in targeting NPS are needed to make a more definitive assessment of the efficacy of these medications in the relief of NPS.

References

Dec 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·A L Nyth, C G Gottfries
Jan 1, 1989·The American Journal of Psychiatry·B V ReiflerP McLean
Jan 1, 1996·The Journal of Neuropsychiatry and Clinical Neurosciences·G PetraccaS E Starkstein
Feb 3, 1998·The Journal of Neuropsychiatry and Clinical Neurosciences·A P Auchus, C Bissey-Black
Jan 29, 2000·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·C MagaiD Gomberg
Jun 30, 2001·Archives of Gerontology and Geriatrics. Supplement·S GaberA Biagi
Aug 10, 2001·International Psychogeriatrics·G M PetraccaS E Starkstein
Aug 17, 2002·Biological Psychiatry·Constantine G Lyketsos, Jason Olin
Oct 13, 2006·The New England Journal of Medicine·Lon S SchneiderUNKNOWN CATIE-AD Study Group
Sep 12, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Bruce G PollockKimberly A Huber
Jan 21, 2010·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Paul B RosenbergUNKNOWN DIADS-2 Research Group
Mar 12, 2010·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Daniel WeintraubUNKNOWN DIADS-2 Research Group
Jul 19, 2011·Lancet·Henry Brodaty
Jan 10, 2012·Journal of Geriatric Psychiatry and Neurology·Matthew E PetersUNKNOWN DIADS-2 Research Group
Jan 24, 2012·Lancet·Amir A SepehryClaudia Jacova
Oct 4, 2012·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Cynthia A MunroUNKNOWN Depression in Alzheimer’s Disease Study–2 Research Group
Dec 22, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Renee RomeoSube Banerjee
May 4, 2013·The American Journal of Psychiatry·Kara ZivinHelen C Kales
May 28, 2013·Neuroscience and Biobehavioral Reviews·Ludwig TrilloAhmad Salehi
Dec 10, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Crystal V Flynn LongmireUNKNOWN DIADS-2 Research Group
Feb 20, 2014·JAMA : the Journal of the American Medical Association·Gary W Small
Feb 20, 2014·JAMA : the Journal of the American Medical Association·Anton P PorsteinssonUNKNOWN CitAD Research Group
Mar 19, 2014·Journal of the American Geriatrics Society·Helen C KalesUNKNOWN Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia
Mar 26, 2014·Current Treatment Options in Psychiatry·Aaron M Koenig, Meryl A Butters
Aug 26, 2014·Expert Review of Neurotherapeutics·Anton P PorsteinssonInga M Antonsdottir
Nov 19, 2014·Neurodegenerative Disease Management·Anton P PorsteinssonJessica S Smith
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Filipa Novais, Sergio Starkstein

❮ Previous
Next ❯

Citations

Jan 12, 2017·Drugs & Aging·Andrew H Ford, Osvaldo P Almeida
May 20, 2019·Journal of Alzheimer's Disease : JAD·Richard J Elsworthy, Sarah Aldred
Jun 25, 2018·Current Psychiatry Reports·Mairead M BartleyMaria I Lapid
Apr 5, 2019·Neuroscience Letters·Saikat ChakrabortyHongxin Dong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

JAMA : the Journal of the American Medical Association
Pierre Tariot
JAMA : the Journal of the American Medical Association
Martin Steinberg, Constantine Lyketsos
Expert Review of Neurotherapeutics
Anton P PorsteinssonInga M Antonsdottir
© 2022 Meta ULC. All rights reserved